Ferndale Laboratories, Inc.
Ferndale Laboratories, Inc. (DBA Ferndale Contract Manufacturing) is a Ferndale, Michigan-based FDA-registered contract pharmaceutical manufacturer specializing in liquid and semisolid drug production, serialization, and packaging for big and small pharma clients.
- Company typePrivate
- Founded1990
- HeadquartersFerndale, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ferndale Laboratories, Inc. does
Ferndale Laboratories, Inc., operating under the trade name Ferndale Contract Manufacturing, is a privately held contract pharmaceutical manufacturer headquartered in Ferndale, Michigan. The company operates as a subsidiary of Ferndale Pharma Group, a diversified pharmaceutical conglomerate. Ferndale Contract Manufacturing specializes in the production of liquid and semisolid pharmaceutical products, with services spanning the full product lifecycle — from analytical method development, formulation optimization, and clinical trial supply production, through commercial compounding and packaging, to quality assurance, stability testing, validation, regulatory affairs support, artwork design, and warehousing. The company's customer base consists of both large and small pharmaceutical companies requiring FDA-registered manufacturing capacity for liquids and semisolids.
The company's manufacturing operations are housed in an FDA-registered drug production facility compliant with FDA 21 CFR Part 11 standards. A core technical differentiator is its Drug Supply Chain Security Act (DSCSA)-compliant serialization and aggregation capability, built on equipment and software from industry providers including Optel Group, rfXcel, TraceLink, Zebra, Domino, and Cognex. The firm offers dedicated project managers for each client engagement, with contracts typically structured as multi-year project-based engagements. Pricing is custom and quote-based per project, with no publicly disclosed pricing. Average employee tenure exceeds 10 years, providing interdepartmental institutional knowledge that the company positions as a service-quality advantage.
Ferndale Contract Manufacturing operates as a B2B sales-led organization reaching clients primarily through its website (with a contact form), direct phone outreach, and the Ferndale Pharma Group careers platform (Paylocity). The firm is privately held with no public ticker, no disclosed external funding rounds, and no disclosed revenue. The firm publicly references over 30 years of operational longevity in the contract manufacturing space. During the COVID-19 pandemic in April 2020, the company pivoted operations to produce hand sanitizer using the World Health Organization formula, donating over 10,000 units to medical personnel and first responders.
Ferndale Laboratories, Inc. firmographics
Firmographics- Name
- Ferndale Laboratories, Inc.
- Legal name
- Ferndale Laboratories, Inc.
- Website
- https://ferndalelabs.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Ferndale Laboratories, Inc. (DBA Ferndale Contract Manufacturing) is a Ferndale, Michigan-based FDA-registered contract pharmaceutical manufacturer specializing in liquid and semisolid drug production, serialization, and packaging for big and small pharma clients.
- Ownership category
- akta.pro rank
Ferndale Laboratories, Inc. industry classification
Industry- Product category
- Contract Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industry
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where Ferndale Laboratories, Inc. is headquartered
LocationHeadquarters
- HQ city
- Ferndale
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Ferndale Laboratories, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contract Pharmaceutical Manufacturing: Provides end-to-end contract manufacturing services for pharmaceutical and related products including development (analytical method development, clinical trial supply, formulation optimization), manufacturing (compounding, packaging), quality assurance/control, and supporting services (regulatory affairs, warehousing). Revenue is generated through project-based manufacturing contracts with pharmaceutical clients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Ferndale Laboratories, Inc. product offering
Product offeringCore offering
Ferndale Laboratories, Inc., doing business as Ferndale Contract Manufacturing, is an FDA-registered contract pharmaceutical manufacturer specializing in liquids and semisolids. The company delivers end-to-end services spanning development (analytical method development and validation, clinical trial supply production, formulation/process optimization, process scale-up, packaging compatibility), manufacturing (compounding and packaging with DSCSA-compliant serialization and aggregation), quality services (assurance, control, stability testing, validation), and supporting services (artwork design, regulatory affairs, warehousing).
Product overview
Ferndale Contract Manufacturing is a contract pharmaceutical manufacturing service provider offering a comprehensive suite of services for drug development and production. The company operates a platform of integrated services organized into four main areas: Development Services (analytical method development, clinical trial supply, formulation optimization, scale-up, packaging compatibility), Manufacturing Services (compounding and packaging of liquids and semisolids), Quality Services (assurance, control, stability testing, validation), and Other Services (artwork design, regulatory affairs, warehousing). The company is an FDA-registered drug manufacturer specializing in liquids and semisolids, with over 30 years of operational experience and state-of-the-art serialization capabilities for DSCSA compliance.
Differentiator
Problem solved
Functional benefit
Products and services
- Development Services Comprehensive pharmaceutical development offerings including analytical method development and validation, clinical trial supply production, formulation and process optimization, process scale-up, and packaging compatibility testing for pharmaceutical companies seeking to bring liquid and semisolid products from formula to market.
- Manufacturing Services Core contract manufacturing operations providing compounding and packaging services for pharmaceutical liquids and semisolids, with serialization and aggregation capabilities for Drug Supply Chain Security Act (DSCSA) compliance, serving multiple big and small pharma clients.
- Quality Services Quality assurance, quality control, stability testing, and validation services to ensure pharmaceutical products meet regulatory and industry standards throughout the manufacturing lifecycle.
- Other Services Supporting services including artwork design, regulatory affairs support, and warehousing that complete the contract manufacturing solution for pharmaceutical clients bringing products to market.
Companies that use Ferndale Laboratories, Inc.
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Ferndale Laboratories, Inc. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Ferndale Laboratories, Inc. partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Ferndale Pharma GroupcoreFerndale Contract Manufacturing is a proud member of the Ferndale Pharma Group, an organizational umbrella providing strategic alignment and operational support across pharmaceutical manufacturing entities.
Scale indicators3 records
Recent moves4 records
Expansion highlights3 records
Ferndale Laboratories, Inc. competitors and assessment
Company assessmentDirect peers
- Halo Pharmaceutical: Pharmaceutical CDMO focused on liquids, creams, ointments, and other semisolid formulations with FDA-inspected facilities. Directly comparable niche focus and customer segment to Ferndale.
- CoreRx Pharmaceuticals: Mid-sized CDMO specializing in liquids, semisolids, and oral solid dosage forms for pharmaceutical clients. Closely comparable to Ferndale in size, format specialization, and customer base of small-to-mid pharma companies.
- Alcami Corporation: US-based CDMO offering drug product development, manufacturing, and analytical services for liquids and other dosage forms. Similar mid-market positioning and service platform to Ferndale.
- Recro Gainesville: CDMO providing formulation development and manufacturing of oral solid doses, liquids, and semisolids. Comparable scale and format overlap with Ferndale, serving similar pharma client base.
- LGM Pharma: API and pharmaceutical services provider offering contract manufacturing, development, and distribution. Overlaps with Ferndale in pharmaceutical contract manufacturing and CDMO services for small-to-mid pharma clients.
- Pharmaceutics International (PII): CDMO specializing in formulation development and manufacturing of oral solids, liquids, and semisolids for pharma clients. Highly comparable scope of services and customer profile to Ferndale.
Broad incumbents
- Thermo Fisher Scientific (Patheon): Pharma services division of Thermo Fisher offering end-to-end CDMO services from development through commercial manufacturing. Competes with Ferndale for pharma contract manufacturing, particularly in liquids and semisolids, but at vastly greater scale and global footprint.
- Catalent: Large global pharmaceutical CDMO offering development, manufacturing, and packaging services across multiple dosage forms. Comparable as a contract manufacturer serving pharma clients, but operates at much greater scale and format breadth than Ferndale.
- Aenova Group: European-headquartered pharmaceutical CDMO with broad capabilities including liquids, semisolids, and solids. Direct comparability in liquid/semisolid contract manufacturing with global scale advantages over Ferndale.
Emerging players
- Particle Sciences (Lubrizol): Pharmaceutical CDMO within Lubrizol specializing in complex drug products including liquids, semisolids, and sterile formulations. Comparable as a focused contract manufacturer, though with stronger sterile injectable capabilities than Ferndale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Ferndale Laboratories, Inc. social profiles
Digital presenceFerndale Laboratories, Inc. compliance and trust
Trust signalCompliance1 record
Ferndale Laboratories, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ferndale Laboratories, Inc. leadership team
Management profileNumber of profiles
Ferndale Laboratories, Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ferndale Laboratories, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ferndale Laboratories, Inc.
What does Ferndale Laboratories, Inc. do?
Ferndale Laboratories, Inc., doing business as Ferndale Contract Manufacturing, is an FDA-registered contract pharmaceutical manufacturer specializing in liquids and semisolids. The company delivers end-to-end services spanning development (analytical method development and validation, clinical trial supply production, formulation/process optimization, process scale-up, packaging compatibility), manufacturing (compounding and packaging with DSCSA-compliant serialization and aggregation), quality services (assurance, control, stability testing, validation), and supporting services (artwork design, regulatory affairs, warehousing).
Is Ferndale Laboratories, Inc. a public or private company?
Ferndale Laboratories, Inc. is a private company. It is classified as corporate owned and is currently operating.
When was Ferndale Laboratories, Inc. founded?
Ferndale Laboratories, Inc. was founded in 1990. It employs 101 to 250 people.
Where is Ferndale Laboratories, Inc. based?
Ferndale Laboratories, Inc. is headquartered in Ferndale, United States, in the North America region.
How does Ferndale Laboratories, Inc. make money?
One revenue line is on record: contract Pharmaceutical Manufacturing.
Who are Ferndale Laboratories, Inc.'s main competitors?
Direct peers on record are Halo Pharmaceutical, CoreRx Pharmaceuticals, Alcami Corporation, Recro Gainesville, LGM Pharma and Pharmaceutics International (PII). Broad incumbents are Thermo Fisher Scientific (Patheon), Catalent and Aenova Group. Particle Sciences (Lubrizol) is listed as an emerging player.
Does Ferndale Laboratories, Inc. have an API?
No public API is recorded for Ferndale Laboratories, Inc..
What industry is Ferndale Laboratories, Inc. in?
Ferndale Laboratories, Inc.'s product category is Contract Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325412 and its SIC code is 2833.